Journal Article

Doxycycline may reduce the incidence of aneurysms in haemodialysis vascular accesses

Charles Diskin, Thomas J. Stokes, Linda M. Dansby, Lautrec Radcliff and Thomas B. Carter

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 20, issue 5, pages 959-961
Published in print May 2005 | ISSN: 0931-0509
Published online March 2005 | e-ISSN: 1460-2385 | DOI: http://dx.doi.org/10.1093/ndt/gfh694
Doxycycline may reduce the incidence of aneurysms in haemodialysis vascular accesses

Show Summary Details

Preview

Background. Doxycycline can prevent aortic aneurysms through the inhibition of enzymes that degrade vessel walls. We investigated whether haemodialysis patients who had received one or more courses of doxycycline were at less risk for aneurysms in their vascular accesses than those who had received other antibiotics.

Methods. Three hundred and eight patients undergoing chronic maintenance hemodialysis were evaluated for aneurysm formation after exposure to doxycycline or another antibiotic. Conditional forward logistical analysis using Cox proportional hazards test (SPSS) was performed to determine the potential significance of differences of aneurysm formation between the two groups.

Results. Patients who had received doxycycline appeared to be at lower risk than the control group, but the effect was most obvious in those patients with synthetic grafts.

Conclusions. Doxycycline may have the ability to reduce aneurysm formation in haemodialysis vascular accesses and a large prospective study is warranted.

Keywords: aneurysms; antibiotics; haemodialysis; medications; vascular access

Journal Article.  1332 words.  Illustrated.

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.